Population
12 patients with angiosarcoma of the face and scalp (5 women, 7 men, average age 71 years)
Design
Case_series
Authors
Loading...
Case illustrates dismal outcomes despite standard therapies in facial angiosarcoma; leaves open whether novel approaches might alter prognosis.
Angiosarcoma of the face and scalp is a relentless disease with a poor prognosis that is generally not altered by early surgical excision, radiation, or chemotherapy.
U F Haustein (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: